1 Min Read
Jan 6 (Reuters) - Fate Therapeutics Inc
* Fate Therapeutics Inc - files for resale of up to 20.9 million shares of co's common stock by the selling stockholders - SEC filing Source text: (bit.ly/2jkJRHz) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.